Issue hub
Opioid law decides how governments respond to the overdose crisis: how settlement money is spent, where naloxone and treatment are available, and how fentanyl trafficking is prosecuted. Follow the bills on treatment, harm reduction, settlements, and enforcement.
Live bill results for “opioids” across the regions we cover, using the same search as the rest of the site.
Bill S-4935. Sponsored by Paul Moriarty (Democratic).
Bill A-5722. Sponsored by Aura Dunn (Republican).
Bill 54, An Act to Amend the Opioid Damages and Health Care Costs Recovery Act, bill would give the Government of Canada the right to sue opioid-related manufacturers, wholesalers and consultants to recover health care costs, including aggregate claims with anonymized records. It is at 2nd Reading as of October 23, 2026. Sponsored by Jay MacDonald.
Bill S-2072, MORE Savings Act, removes cost-sharing for certain opioid treatments and recovery services in Medicare and many health plans. It is at Read twice and referred to the Committee on Finance. as of June 12, 2025.
Bill HR-1257, OPIOIDS Act, would support overdose data, forensic testing, drug tracking, and training for first responders and law enforcement. It is at Referred to the House Committee on the Judiciary. as of February 12, 2025.
Bill HR-10649, Safe Disposal of Opioids Act, creates grants for medication disposal sites and a fee on opioid sales, with discounts for eligible patients. It is at Introduced as of October 1, 2026. Sponsored by Suzanne Bonamici (D) and Riley Moore.
Bill HR-10678, Expands grants for fentanyl testing tools, the bill would let certain grant funds be used to buy fentanyl testing kits and overdose reversal drugs. It is at Introduced as of October 1, 2026. Sponsored by Thomas Kean (R), Jefferson Van Drew, Andrew Garbarino, and Michael Lawler.
Bill S-1975, Dark Web Interdiction Act, creates a dark-web drug offense, a federal task force, required reports, and a sentencing guideline increase to combat opioid distribution on dark web marketplaces. It is at Read twice and referred to the Committee on the Judiciary. as of June 5, 2025.
Bill HR-8000, END 7-OH Act, adds synthetic 7-hydroxymitragynine to Schedule I, excluding the compound when naturally in kratom (Mitragyna speciosa). It is at Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 19, 2026.
Bill HRES-1503, Supporting Overdose Awareness Day, house resolution recognizing Overdose Awareness Day and urging action to reduce stigma, support prevention, treatment, harm reduction, and recovery from opioid use disorder. It is at Referred to the House Committee on Energy and Commerce. as of August 31, 2026.
Bill HR-10037, Virtual opioid treatment for veterans, a VA pilot to expand telehealth-based opioid treatment for veterans, combining counseling and medication, coordinating with community providers, plus a study on barriers, over a two-year period. It is at Referred to the Subcommittee on Health. as of August 10, 2026.
Bill SRES-369, Fentanyl Prevention and Awareness Day, designates August 21, 2025, to remember fentanyl victims and promote awareness, prevention, and drug-free choices. It is at Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5520; text: CR S5516) as of August 2, 2025.
Bill SRES-95, National Fentanyl Awareness Week, designates Feb 23–Mar 1, 2025 as a week to raise awareness about fentanyl harms and responses. It is at Referred to the Committee on the Judiciary. (text: CR S1358) as of February 25, 2025.
Bill HR-8005, Counterfeit Pill Prohibition Expansion, expands federal prohibition to include fentanyl and counterfeit pills, requires a DEA operation plan, audits campaigns, and annual data reports to Congress on seizures and enforcement. It is at Received in the Senate and Read twice and referred to the Committee on the Judiciary. as of September 16, 2026.
Bill PR26-0793, Bill would extend outreach grants amid crisis, the DC Council would extend current FY2026 outreach grants using the Opioid Abatement Fund until a permanent program starts. It is at Resolution R26-0515, Effective from Sep 22, 2026 Published in DC Register Vol 73 and Page 012782 as of October 2, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.
Bill B26-0792, Behavioral Health Grants Extended, department would renew Fiscal Year 2027 grants for former FY2026 recipients in Wards 1, 2, 5, and 6, funded by the Opioid Abatement Fund. It is at Transmitted to Mayor, Response Due on November 9, 2026 as of October 9, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, who voted for it, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.
Bill B26-0791, Extend outreach grants for substance use services, the bill would extend 90-day outreach grants for substance-use services in Wards 1, 2, 5, and 6, reissuing FY2026 grants if funds are available. It is at Returned from Mayor as of October 20, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.
This measure would permanently place nitazene opioids in Schedule I, tightening federal controls and affecting researchers, manufacturers, and enforcement efforts.
Maintains and funds a rural opioid prevention, treatment, and recovery grant program run by HRSA.
Permanently places nitazene-class synthetic opioids into Schedule I of the Controlled Substances Act.
